CS logo
small CS logo
Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI)

Entebbe, Uganda
Research institute in Entebbe
51-59 Nakiwogo Rd, Entebbe

About Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI)


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI)


During the past decade, Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11220000Started TrialsCompleted Trails201620170123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment

Rows per page:

0–0 of 0

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI)" #1 collaborator was "Centre Hospitalier Universitaire Vaudois" with 2 trials as a collaborator, "International AIDS Vaccine Initiative" with 2 trials as a collaborator, "MRC/UVRI and LSHTM Uganda Research Unit" with 2 trials as a collaborator, "Auro Vaccines LLC" with 1 trials as a collaborator and "Entebbe General Hospital" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEuroVacc Foundation: 2EuroVacc Foundation: 2International AIDSVaccine Initiative: 2International AIDSVaccine Initiative: 2University of Toronto: 2University of Toronto: 2

Created with Highcharts 11.1.0Top CollaboratorsCentre HospitalierUniversitaire Vaudois: 2Centre HospitalierUniversitaire Vaudois: 2International AIDSVaccine Initiative: 2International AIDSVaccine Initiative: 2MRC/UVRI and LSHTMUganda Research Unit:2MRC/UVRI and LSHTMUganda Research Unit:2Auro Vaccines LLC: 1Auro Vaccines LLC: 1Entebbe General Hospital: 1Entebbe General Hospital: 1GlaxoSmithKline: 1GlaxoSmithKline: 1Ichor Medical SystemsIncorporated: 1Ichor Medical SystemsIncorporated: 1Medical Research Council: 1Medical Research Council: 1UVRI-IAVI HIV VaccineProgram: 1UVRI-IAVI HIV VaccineProgram: 1UVRI-IAVI HIV VaccineProgram, Uganda: 1UVRI-IAVI HIV VaccineProgram, Uganda: 1

Clinical Trials Conditions at Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI)


According to Clinical.Site data, the most researched conditions in "Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI)" are "HIV Infections" (2 trials), "HIV/AIDS" (2 trials), "Foreskin HIV Susceptibility" (1 trials), "HIV" (1 trials) and "Schistosomiasis Mansoni" (1 trials). Many other conditions were trialed in "Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI)" in a lesser frequency.

Clinical Trials Intervention Types at Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI)


Most popular intervention types in "Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI)" are "Biological" (4 trials) and "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "AIDSVAX B/E" (1 trials), "Ad35 investigational HIV vaccine" (1 trials), "Ad35-GRIN/ENV" (1 trials), "Adjuvanted GSK investigational HIV vaccine formulation 1" (1 trials) and "Adjuvanted GSK investigational HIV vaccine formulation 2" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI)


The vast majority of trials in "Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI)" are 5 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI)


Currently, there are NaN active trials in "Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI), undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI), 4 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 1: 4Phase 1: 4Not Applicable: 1Not Applicable: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 5Completed: 5Unknown status: 1Unknown status: 1